Targeting aerosol deposition to and within the lung airways using excipient enhanced growth - Wikidata - wikimedia - TriplyDB

Targeting aerosol deposition to and within the lung airways using excipient enhanced growth

Targeting aerosol deposition to and within the lung airways using excipient enhanced growth

http://www.wikidata.org/entity/Q28390979

about

Fundamentals of aerosol therapy in critical care Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation Targeted Lung Delivery of Nasally Administered Aerosols High-efficiency generation and delivery of aerosols through nasal cannula during noninvasive ventilation Variability in Nose-to-Lung Aerosol Delivery Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo Data Development of high efficiency ventilation bag actuated dry powder inhalers.Development of a new technique for the efficient delivery of aerosolized medications to infants on mechanical ventilation Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.Characterization of a New High-Dose Dry Powder Inhaler (DPI) Based on a Fluidized Bed Design.Bridging the Gap Between Science and Clinical Efficacy: Physiology, Imaging, and Modeling of Aerosols in the Lung.The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy.Development of a high efficiency dry powder inhaler: effects of capsule chamber design and inhaler surface modifications.Development and comparison of new high-efficiency dry powder inhalers for carrier-free formulations.Advances in inhaled technologies: understanding the therapeutic challenge, predicting clinical performance, and designing the optimal inhaled product.Dry powder inhalation: past, present and future.Spray-dried particles as pulmonary delivery system of anti-tubercular drugs: design, optimization, in vitro and in vivo evaluation.Validating Whole-Airway CFD Predictions of DPI Aerosol Deposition at Multiple Flow Rates.Aerosol Drug Delivery During Noninvasive Positive Pressure Ventilation: Effects of Intersubject Variability and Excipient Enhanced Growth.Small Airway Absorption and Microdosimetry of Inhaled Corticosteroid Particles after Deposition.Pulmonary aerosol delivery and the importance of growth dynamics.Perspective: Aerosol microphysics: From molecules to the chemical physics of aerosols.

P2860

Q28068836-C5D6BF98-2223-427E-8D9F-632A17CBEE33 Q28387314-3BF0D0DC-A75B-438A-92E3-EDAAAC77258F Q28387568-8C17F039-DD7C-4A13-896D-F7BB825B9838 Q28390968-08C61FFF-6F2B-4126-B048-D8CE1A5BDEE1 Q28395392-0B744333-7C32-40B4-A071-A93019BF74EE Q30945192-64150F32-F2B8-4C6B-8666-E513ACB5D3A5 Q33732483-952825B5-9D6A-42E9-AFD0-CCCF0F9E40BA Q34861310-AF1B0B9C-6E2C-4A5D-A044-6EC587F1BF18 Q36024362-DD0FFC03-D427-4D20-9CD4-DAF8B4441CB4 Q36200226-2C4CA35E-8A9C-46B5-B6CB-0D44495DDD7F Q36827889-5FB4724E-B00A-4805-8BCF-D775A9BA1AB1 Q37238872-95266301-1781-4613-9F6C-1D449103C082 Q37625308-9F0041C5-C5FB-4C79-8E35-591E521D3AC3 Q37626575-2E3D4621-FCDE-4AE5-98D5-D73DF5612DF1 Q38185862-5174293F-321C-430E-8CF7-71030533AF0F Q38830375-72D5D283-8F50-4CBD-9709-7C0474639916 Q38967890-78C6AF68-E531-40D8-9710-9771ECA88972 Q39848034-3E022F4B-1101-4F4D-8F72-6E02D83B839E Q45050545-8F13F9F6-7FC7-440E-B928-92E3A5E65479 Q45061912-A5B376DB-99AF-43E6-87C3-1920F1B45A1B Q47362335-B6E1A55D-B437-4B01-B214-1D1F96573A96 Q48108623-FE673012-D977-4819-B803-A4E7E3317C5D

P2860

Targeting aerosol deposition to and within the lung airways using excipient enhanced growth

http://www.wikidata.org/entity/Q28390979

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Targeting aerosol deposition t ...... sing excipient enhanced growth

@ast

Targeting aerosol deposition t ...... sing excipient enhanced growth

@en

Targeting aerosol deposition t ...... sing excipient enhanced growth

@nl

type

label

Targeting aerosol deposition t ...... sing excipient enhanced growth

@ast

Targeting aerosol deposition t ...... sing excipient enhanced growth

@en

Targeting aerosol deposition t ...... sing excipient enhanced growth

@nl

prefLabel

Targeting aerosol deposition t ...... sing excipient enhanced growth

@ast

Targeting aerosol deposition t ...... sing excipient enhanced growth

@en

Targeting aerosol deposition t ...... sing excipient enhanced growth

@nl

P1433

Q28390979-878B8269-CCA0-4C39-B8AF-739E1CD8C5B1

P1476

Q28390979-122330B4-684E-4928-BD37-14509EEB5CB5

P2093

Q28390979-6B9D5945-F58C-405F-80E4-E394DB7E3B8F

Q28390979-D3793EBE-3CC5-41DE-94CF-77058E77AE08

Q28390979-FEE3DFA3-CF0A-4914-8B49-AB4051509B4C

P2860

Q28390979-00CECF85-8608-4662-9337-178F654BCE7C

Q28390979-07D5C132-F5AF-4326-9DB7-7304951D3FE1

Q28390979-09F79514-B473-44D8-80FC-FA311F9175EA

Q28390979-115E8A14-50DF-48D3-A800-E575D752FB11

Q28390979-16740A0D-A0A3-4EC0-BF5F-5A2EEF4EB9B1

Q28390979-1C26F452-D851-475D-B869-C7C815EA11B9

Q28390979-31A4514D-DB59-420D-B2F7-93DF40E99DB3

Q28390979-33324FDA-FC88-451B-BA7B-2E53B7069348

Q28390979-3AAE3170-A0C4-453E-9CBA-A2163B9107AC

Q28390979-40D26290-5C4C-49C7-96FA-84540BCE6E45

P304

Q28390979-8F3AF4F7-B3A2-440C-A6BE-3241120E0B72

P31

Q28390979-8214C36A-1EAD-4EE7-AD51-A5F3267FFE72

P3181

Q28390979-0C1EE84A-2152-4A5A-92B9-04E20ABD2B25

P356

Q28390979-1C103365-C6FF-4F6E-A25B-DE62EA150AC2

P407

Q28390979-9FA1882D-4EE2-4C7E-9D36-E35F82A94C9B

P433

Q28390979-7E9D6DDF-74CF-4092-8CF9-D4CF31AF364F

P478

Q28390979-7DD0CF1E-DFDC-472E-B2A7-A759A728DE48

P50

Q28390979-F1F4B3DD-B00F-4C12-AA15-BA42EAA602D2

P577

Q28390979-9EB77232-D4C5-47AE-902B-B50E61379AF7

P5875

Q28390979-163E7D8D-6723-4D6B-8842-B711ED0468B9

P698

Q28390979-E71183E8-3F54-4434-BC1D-FF52591D1BEC

P921

Q28390979-01F00055-94D5-4F0C-92C8-C1BD731CA2FA

P932

Q28390979-CA312C09-144F-4E24-996A-118B11AED95E

P3181

P356

P1433

Journal of Aerosol Medicine and Pulmonary Drug Delivery

P1476

Targeting aerosol deposition t ...... sing excipient enhanced growth

@en

P2093

Geng Tian

http://www.w3.org/2001/XMLSchema#string

P Worth Longest

http://www.w3.org/2001/XMLSchema#string

Xiang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Aerosol deposition in the extrathoracic region

CFD simulations of enhanced condensational growth (ECG) applied to respiratory drug delivery with comparisons to in vitro data

Characterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airways

Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance

Characterization of Nanoaerosol Size Change During Enhanced Condensational Growth

Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model

An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques.

Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.

Effects of mesh style and grid convergence on particle deposition in bifurcating airway models with comparisons to experimental data.

Evaluation of the Respimat Soft Mist Inhaler using a concurrent CFD and in vitro approach.

P304

248-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3093799

http://www.w3.org/2001/XMLSchema#string

P356

10.1089/JAMP.2012.0997

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

234049712

http://www.w3.org/2001/XMLSchema#string

P698

23286828

http://www.w3.org/2001/XMLSchema#string

P921

P932

3826577

http://www.w3.org/2001/XMLSchema#string